Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer
Aimée R. Kreimer(National Cancer Institute), Tim Waterboer(German Cancer Research Center), Mark P. Purdue(Government of the United States of America), Dana Holzinger(German Cancer Research Center), Mattias Johansson(Centre international de recherche sur le cancer), Ruth M. Pfeiffer(National Institutes of Health), Craig Williams(The University of Adelaide), Allan Hildesheim(Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud), Martina Willhauck‐Fleckenstein(National Institutes of Health), Elizabeth L. Yanik(National Cancer Institute), David P. Check(National Institutes of Health), Angelika Michel(German Cancer Research Center), Michael Pawlita(DKFZ-ZMBH Alliance), Neal D. Freedman(National Institutes of Health), Krystle A. Lang Kuhs(University of Kentucky), Paul Brennan(Centre international de recherche sur le cancer), Wen‐Yi Huang(National Institutes of Health), Hormuzd A. Katki(Cancer Genetics (United States))
Cited by 102
Related Papers
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
|Nature|2008|1.3k
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
|New England Journal of Medicine|2012|1k
Selection Criteria for Lung-Cancer Screening
|New England Journal of Medicine|2013|1k